Synthesis and calcium antagonist activity of 1,4-dihydropyridines containing phenylaminoimidazolyl substituents

Farmaco

Volumn 58, Issue 11, 2003, Pages 1077-1081

  Zarghi, A ^a   Sadeghi, H ^b   Fassihi, A ^b   Faizi, M ^a   Shafiee, A ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Calcium channel anatagonists; Dihyropyridines; Nifedipine analogues; Phenylaminoimidazoles

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; 3,5 DI TERT BUTYL 1,4 DIHYDRO 2,6 DIMETHYL 4 (2 METHYLTHIO 1 PHENYLAMINO 5 IMIDAZOLYL) 3,5 PYRIDINEDICARBOXYLATE; 3,5 DIBENZYL 1,4 DIHYDRO 2,6 DIMETHYL 4 (2 METHYLTHIO 1 PHENYLAMINO 5 IMIDAZOLYL) 3,5 PYRIDINEDICARBOXYLATE; 3,5 DIETHYL 1,4 DIHYDRO 2,6 DIMETHYL 4 (2 METHYLTHIO 1 PHENYLAMINO 5 IMIDAZOLYL) 3,5 PYRIDINEDICARBOXYLATE; 3,5 DIISOPROPYL 1,4 DIHYDRO 2,6 DIMETHYL 4 (2 METHYLTHIO 1 PHENYLAMINO 5 IMIDAZOLYL) 3,5 PYRIDINEDICARBOXYLATE; 3,5 DIMETHYL 1,4 DIHYDRO 2,6 DIMETHYL 4 (2 METHYLTHIO 1 PHENYLAMINO 5 IMIDAZOLYL) 3,5 PYRIDINEDICARBOXYLATE; 3,5 DIPHENETHYL 1,4 DIHYDRO 2,6 DIMETHYL 4 (2 METHYLTHIO 1 PHENYLAMINO 5 IMIDAZOLYL) 3,5 PYRIDINEDICARBOXYLATE; 3,5 DIPHENPROPYL 1,4 DIHYDRO 2,6 DIMETHYL 4 (2 METHYLTHIO 1 PHENYLAMINO 5 IMIDAZOLYL) 3,5 PYRIDINEDICARBOXYLATE; 3,5 DIPROPYL 1,4 DIHYDRO 2,6 DIMETHYL 4 (2 METHYLTHIO 1 PHENYLAMINO 5 IMIDAZOLYL) 3,5 PYRIDINEDICARBOXYLATE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CARBENE; ESTER DERIVATIVE; NIFEDIPINE; POTASSIUM; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG SYNTHESIS; GUINEA PIG; SMOOTH MUSCLE;

EID: 0142155716     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(03)00159-9     Document Type: Article

References (21)

1. Fleckenstien A. Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular smooth muscle. Ann. Rev. Pharmacol. Toxicol. 17:1977;149.
2. Goldmann S., Stoltefuss I. 1,4-Dithydropyridines: effects of chirality and conformation on the calcium antagonist and calcium agonist activities. Angew. Chem., Int. Ed. Engl. 30:1991;1559.
3. Triggle D.G. Biochemical and pharmacologic differences among calcium channel antagonists: clinical implication. Epstein M. Calcium Antagonists in Clinical Medicine. 1992;p. I. Hanley and Befus, Philadelphia.
4. Ramesh M., Woloyk M.W. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-pyridyl)]-3,5-pyridinedi carboxylates. Drug Des. Discov. 8:1992;313.
5. Vo D., Matowe W.C., Ramesh M., et al. Synthesis, calcium channel agonist antagonist modulation activities and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl pyridine-5-carboxylate racemates and enantiomers. J. Med. Chem. 38:1995;2851.
6. Mahmoudian M., Mirkhani H., Nehardani Z., et al. Synthesis and biological activity of two new calcium-channel blockers, mebudipine and dibudipine. J. Pharm. Pharmacol. 49:1997;1229.
7. Ramesh M., Matowe W.C., Wolowyk M.W., et al. Synthesis and calcium channel antagonist activity of alkyl t-butylesters of nifedipine contaning pyridinyl substituents. Drug Des. Deliv. 2:1987;79.
8. Akula M.R., Matowe W.C., Wolowyk M.W., et al. Synthesis and calcium channel antagonist activity of 3-arylmethyl 5-isopropyl 1,4-dihydro-2,6- dimethyl-4-(pyridyl)-3,5-pyridinedicarboxylates. Pharm. Res. 7:1990;919.
9. Akula M.R., Motowe W.C., Wolowylk M.W., et al. Synthesis and calcium channel antagonist activity of alkyl cycloalkylesters of nifedipine containing pyridinyl substituents. Drug Des. Deliv. 5:1989;117.
10. Shafiee A., Dehpour A.R., Hadizadeh F., et al. Synthesis and calcium channel antagonist activity of nifedipine analogues with methylsulfonylimidazolyl substituent. Pharm. Acta Helv. 73:1998;75.
11. Amini A., Dehpour A.R., Shafiee A., et al. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloromidazolyl substituents. Arzneim. Forsch./Drug Res. 52:2002;21.
12. Baraldi P., Garuti L., Leonin A., et al. Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5- pyridinedicarboxylates. Drug Des. Discov. 10:1993;319.
13. Shafiee A., Miri R., Dehpour A.R., et al. Synthesis and calcium cannel antagonist-activity of nifedipine analogues containing nitroimidazolyl substituents. Pharm. Sci. 2:1996;541.
14. Pourmoread F., Hadizadeh F., Shafiee A. Synthesis and calcium channel antagonist activity of 4-imidazolyl-1,4-dihy-dropyridines. Pharm. Sci. 3:1997;165.
15. Shafiee A., Rastkary N., Jorjani M. Synthesis and calcium channel antagonist-activity of 1,4-dihyropyridine derivatives containing 4-nitroimidazolyl substituents. Arzneim. Forsch. 52:2002;537.
16. Zarghi A., Derakhshandeh K., Roshanzamir F., et al. Synthesis and calcium channel antagonist-activity of new 1,4-dihyropyridines containing nitrobenzylimidazolyl substituent. Boll. Chim. Farmac. 141:2002;15.
17. Dener J.M., Zhang L.H., Rapoport H. An effective chirospecific synthesis of (+)pilocarpine from L-aspartic acid. J. Org. Chem. 58:1993;1159.
18. Hantzsch A. Uber die Synthese pyridinartiger Verbindungen aus Acetessigather and Aldehydammoniak. Justus Lie-bigs Ann. Chem. 215:1882;1.
19. Iwanami M., Shibanuama T., Fujimoto M., et al. Synthesis of new water soluble dihydropyridine vasodilators. Chem. Pharm. Bull. 27:1979;1426.
20. 3H] nitrendipine to guinea pig ileal smooth muscle. J. Pharm. Exp. Ther. 225:1983;291.
21. Rovnyak G.C., Atwal K.S., Hedberg A., et al. Dihydropyridine calcium channel blockers: basic 3-substituted 4-aryl-1,4-dihydropyridine-5-carboxylic acid esters, potent anti-hypertensive agent. J. Med. Chem. 35:1992;3236.